Gilead Sciences has agreed to purchase the remainder of improvement accomplice Arcellx in a deal that values the biotechnology firm at about $7.8 billion at closing.
Source link
Gilead Sciences to Buy Arcellx in Deal Valued at $7.8 Billion
Related Posts
Elon Musk Gambles Billions in Memphis to Catch Up on AI
xAI is aiming to win the tech arms race with its “Colossus” knowledge facilities, thrown up at lightning pace, however…
The 17 Best Gifts for Plant Lovers We’d Buy Ourselves (2025)
Ostensibly, plant lovers needs to be the simplest to buy. Simply get them a plant, proper? Incorrect. (Nicely, more often…
Ranked: the 20 Best Suburbs in the US to Live in 2025
2025-09-07T12:42:01Z Share Facebook Email X LinkedIn Reddit Bluesky WhatsApp Copy link lighning bolt icon An icon in the shape of…